GlaxoSmithKline (Australia)

InstitutionResearch output, impact & collaborations

GlaxoSmithKline (Australia) is a research organisation in Melbourne, AU. OpenAlex records 221 works and 17,420 citations for it. 55 researchers list it as their most recent affiliation.

221

Works

17,420

Citations

Researchers

Avg h-index

IDs:ROR OpenAlex

How has GlaxoSmithKline (Australia)'s publication output changed over time?

ScholarIQpublication output · 2012–2020

Output grew0% over the shown period — from 1 works in 2012 to 1 in 2020.

20122020

What are the most-cited papers on GlaxoSmithKline (Australia)?

ScholarIQmost cited works

Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial

Paolo A. Ascierto, Michele Del Vecchio, Mario Mandalà, Helen Gogas, Ana Arance, Stéphane Dalle, C. Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion‐Sileni, Iván Márquez‐Rodas, Marcus O. Butler, Michele Maio, Mark R. Middleton, Luis de la Cruz‐Merino, Petr Arenberger, Victoria Atkinson, Andrew Hill, Leslie A. Fecher, Michael Millward, Nikhil I. Khushalani, Paola Queirolo, Maurice Lobo, Veerle de Pril, John T. Loffredo, James Larkin, Jeffrey S. Weber

The Lancet Oncology. 2020528 Citations

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic <i>BRAF</i> -Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

Kevin B. Kim, Richard Kefford, Anna C. Pavlick, Jeffrey R. Infante, Antoni Ribas, Jeffrey A. Sosman, Leslie A. Fecher, Michael Millward, Grant A. McArthur, Patrick Hwu, René González, Patrick A. Ott, Georgina V. Long, Olivia Gardner, Danièle Ouellet, Yanmei Xu, Douglas J. DeMarini, Ngocdiep T. Le, Kiran Patel, Karl D. Lewis

Journal of Clinical Oncology. 2012478 CitationsOPEN ACCESS